Psyence Biomedical Ltd. (PBM) Income from Continuing Operations (2023 - 2025)
Psyence Biomedical (PBM) posted quarterly Income from Continuing Operations of 1504977.0 for Q3 2025, down 230.18% year-over-year from 1156102.0 in Q3 2024, and down 230.18% quarter-over-quarter from 1156102.0 in Q3 2024.
Psyence Biomedical Ltd. (PBM) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Psyence Biomedical's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 1504977.0 for Q3 2025.
- In Q3 2025, Income from Continuing Operations fell 230.18% year-over-year to 1504977.0; the TTM figure through Sep 2025 stood at 3759909.0 (changed N/A YoY), while the FY2026 annual figure was 6891442.0, down 88.35% from the prior year.
- Income from Continuing Operations for Q3 2025 stood at 1504977.0, down from 1156102.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1156102.0 in Q3 2024, with the low at 3234869.0 in Q1 2023.
- The 3-year median for Income from Continuing Operations is 840571.0 (2023), against an average of 939977.25.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations surged 756.26% in 2024, then slumped 230.18% in 2025.
- Psyence Biomedical's Income from Continuing Operations stood at 176165.0 in 2023, then soared by 756.26% to 1156102.0 in 2024, then plunged by 230.18% to 1504977.0 in 2025.
- Business Quant data shows PBM's Income from Continuing Operations at 1504977.0 in Q3 2025, 1156102.0 in Q3 2024, and 176165.0 in Q3 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.50 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2023 | -176,165.00 |
| Mar 31, 2023 | -3.23 Mn |